HEALTH● LOWOct 2 · Oct 2, 2026, 7:40 PM
Biogen phase 2 litifilimab data boosts lupus candidate
Seeking Alpha Tech · global
New data from Biogen's phase 2 trial for litifilimab suggests it is a promising candidate for treating lupus. This development could advance treatment options for the disease.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH7m agoFG releases ₦40.7 billion for primary healthcare, expands coverage to 13,000 facilitiesPremium TimesHEALTH14m agoAmericans with disabilities worried over plan to slash national health surveyThe Independent WorldHEALTH25m agoWATCH: Measles, GLP-1s and anti-aging: How to protect your healthABC NewsHEALTH35m agoKenya Announces Second Ebola Case, Says ‘No Evidence’ Of Wider SpreadChannels TV